Opinion statement
Hemifacial spasm (HFS) is a peripheral movement disorder caused by direct or indirect compression or distortion of the root exit zone of the seventh cranial nerve, which is most commonly compressed by an arterial loop, but also may be compressed by a tumor, cyst, or aneurysm. All patients with HFS should undergo magnetic resonance imaging, with particular attention to the seventh cranial nerve. For patients with HFS who want treatment, there are three options. Oral medications, particularly anticonvulsants, may be useful, but the response rate is low and evidence is almost exclusively anecdotal. Local injection of botulinum toxin into the overactive muscles has a very high rate of success and virtually no serious side effects. Backed by controlled clinical trials, the authors consider it the treatment of choice. Microvascular surgical decompression has the advantage of being potentially curative, and obviates the need for chronic injections with botulinum toxin. However, surgery carries much greater risk than botulinum toxin and the spasm may recur. It is important that surgery is carried out by an experienced neurosurgeon to reduce the risk.
This is a preview of subscription content, access via your institution.
References and Recommended Reading
Wang A, Jankovic J: Hemifacial spasm: clinical findings and treatment. Muscle Nerve 1998, 21:1740–1747. This is the most recent large series, with observations on clinical characteristics, demographics, response to treatment, and literature review.
Digre K, Corbett JJ: Hemifacial spasm: differential diagnosis, mechanism, and treatment. Adv Neurol 1988, 49:151–176.
Tan NC, Chan LL, Tan EK: Hemifacial spasm and involuntary facial movements. Q J Med 2002, 95:493–500.
Tan EK, Jankovic J: Bilateral hemifacial spasm: a report of five cases and a literature review. Mov Disord 1999, 14:345–349.
Miwa H, Mizuno Y, Kondo T: Familial hemifacial spasm: report of cases and review of literature. J Neurol Sci 2002, 193:97–102.
Wartenberg R: Hemifacial Spasm. New York: Oxford Press; 1952.
Evidente VG, Adler CH: Hemifacial spasm and other craniofacial movement disorders. Mayo Clin Proc 1998, 73:67–71. This is nice review of the differential diagnosis of HFS.
Auger RG, Whisnant JP: Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984. Arch Neurol 1990, 47:1233–1234.
Nielsen VK: Electrophysiology of the facial nerve in hemifacial spasm: ectopic/ephaptic excitation. Muscle Nerve 1985, 8:545–555.
Moller AR, Jannetta PJ: On the origin of synkinesis in hemifacial spasm: results of intracranial recordings. J Neurosurg 1984, 61:569–576.
Jannetta PJ, Abbasy M, Maroon JC, et al.: Etiology and definitive microsurgical treatment of hemifacial spasm: operative techniques and results in 47 patients. J Neurosurg 1977, 47:321–328.
Adler CH, Zimmerman RA, Savino PJ, et al.: Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol 1992, 32:502–506.
Galvez-Jimenez N, Hanson MR, Desai M: Unusual causes of hemifacial spasm. Semin Neurol 2001, 21:75–83.
Tan EK, Jankovic J: Psychogenic hemifacial spasm. J Neuropsychiatry Clin Neurosci 2001, 13:380–384.
Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N Engl J Med 1991, 324:1186–1194.
Alexander GE, Moses H: Carbamazepine for hemifacial spasm. Neurology 1982, 32:286–287.
Patel J, Naritoku DK: Gabapentin for the treatment of hemifacial spasm. Clin Neuropharmacol 1996, 19:185–188.
Bandini F, Mazzella L: Gabapentin as treatment for hemifacial spasm. Eur Neurol 1999, 42:49–51.
Daniele O, Caravaglios G, Marchini C, et al.: Gabapentin in the treatment of hemifacial spasm. Acta Neurol Scand 2001, 104:110–112.
Herzberg L: Management of hemifacial spasm with clonazepam. Neurology 1985, 35:1676–1677.
Sandyk R, Gillman MA: Baclofen in hemifacial spasm. Int J Neurosci 1987, 33:261–264.
Frueh BR, Felt DP, Wojno TH, Musch DC: Treatment of blepharospasm with botulinum toxin: preliminary report. Arch Ophthalmol 1984, 102:1464–1468.
Savino PJ, Sergott RC, Bosley TM, Schatz NJ: Hemifacial spasm treated with botulinum toxin A injection. Arch Ophthalmol 1985, 103:1305–1306.
Mauriello JA: Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology 1985, 35:1499–1500.
Kraft SP, Lang AE: Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci 1988, 15:276–280.
Jitpimolmard S, Tiamkao S, Laopaiboon M: Long term results of botulinum toxin A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry 1998, 64:751–757.
Jankovic J, Schwartz K, Donovan DT: Botulinum toxin treatment of crani-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurgery Psychiatry 1990, 53:633–639.
Elston JS: The management of blepharospasm and hemifacial spasm. J Neurol 1992, 239:5–8.
Hsiung GY, Das SK, Ranawaya R, et al.: Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 2002, 17:1288–1293.
Defazio G, Abbruzzese G, Girlanda P, et al.: Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 2002, 59:418–420.
Jost WH, Kohl A: Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 2001, 248(suppl):21–24.
Yoshimura DM, Aminoff MJ, Tami TA, Scott AB: Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve 1992, 15:1045–1049.
Park YC, Lim JK, Lee DK, Yi SD: Botulinum A toxin treatment of hemifacial spasm and blepharospasm. J Korean Med Sci 1993, 8:334–340.
Gardner WJ, Sava GA: Hemifacial spasm: a reversible pathophysiologic state. J Neurosurg 1962, 19:240–247.
Barker FG, Jannetta PJ, Bissonette DJ, et al.: Microvascular decompression for hemifacial spasm. J Neurosurg 1995, 82:201–210.
Huang C-I, Chen I-H, Lee L-S: Microvascular decompression for hemifacial spasm: analysis of operative findings and results in 310 patients. Neurosurgery 1992, 30:53–57.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kemp, L.W., Reich, S.G. Hemifacial spasm. Curr Treat Options Neurol 6, 175–179 (2004). https://doi.org/10.1007/s11940-004-0009-4
Issue Date:
DOI: https://doi.org/10.1007/s11940-004-0009-4
Keywords
- Facial Nerve
- Botulinum Toxin
- Gabapentin
- Baclofen
- Main Side Effect